ASPX Insider Trading Activity and SEC Form 4 Filings
ASPX insider trading summary
No open-market insider purchases or sales of Auspex Pharmaceuticals, Inc. (ASPX) have been reported on SEC Form 4 in the past 12 months.
Latest ASPX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 16, 2015 | David A Stamler | Chief Medical Officer | Sell | $32K (400 @ $79.55) |
| Mar 16, 2015 | David A Stamler | Chief Medical Officer | Sell | $208K (2,600 @ $80.08) |
| Feb 13, 2015 | CMEA Ventures VII LP | 10% Owner | Sell | $66K (1,047 @ $62.98) |
| Feb 13, 2015 | Cmea Ventures Vii (parallel) LP | 10% Owner | Sell | $2.6M (40,786 @ $62.98) |
| Feb 13, 2015 | CMEA Ventures VII LP | 10% Owner | Sell | $2.6M (40,786 @ $62.98) |
| Feb 13, 2015 | Cmea Ventures Vii (parallel) LP | 10% Owner | Sell | $66K (1,047 @ $62.98) |
| Feb 12, 2015 | Cmea Ventures Vii (parallel) LP | 10% Owner | Sell | $4.2M (66,138 @ $62.96) |
| Feb 12, 2015 | Cmea Ventures Vii (parallel) LP | 10% Owner | Sell | $811K (12,675 @ $64.00) |
| Feb 12, 2015 | CMEA Ventures VII LP | 10% Owner | Sell | $107K (1,696 @ $62.96) |
| Feb 12, 2015 | Cmea Ventures Vii (parallel) LP | 10% Owner | Sell | $21K (325 @ $64.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.